| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.003 | 1 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.00094 | 1 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.00094 | 1 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.00091 | 1 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.00084 | 1 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.0011 | 1 |